Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
MRI-kenmerken voorspellen tijd tot eerste symptomen Alzheimer
aug 2018 | Dementie